A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine
Clinical trial NCT05238441 · UNKNOWN
Trial details
- NCT number
- NCT05238441
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-20
- Primary completion
- 2022-06-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.